Determinants of excess mortality following unprotected left main stem percutaneous coronary intervention

O A Alabas1, R A Brogan2, M Hall1

  • 1MRC Bioinformatics Unit, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK.

Insights

Long-term survival after unprotected left main stem PCI varies by patient condition. Survival is high for stable angina but poor for STEMI with cardiogenic shock, influenced by factors like renal failure and ventilation needs.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Health Outcomes Research

Background:

  • Limited long-term outcome data exist for unprotected left main stem percutaneous coronary intervention (UPLMS PCI).
  • Assessing 5-year survival requires accounting for background population mortality.

Purpose of the Study:

  • To evaluate the 5-year survival rates for patients undergoing UPLMS PCI.
  • To identify predictors of excess mortality in different patient subgroups.

Main Methods:

  • A population-based registry of 10,682 UPLMS PCI cases (2005-2014) was analyzed.
  • Cases were matched to UK death data for 56.6 million people.
  • Relative survival and excess mortality were estimated.

Main Results:

  • Crude 5-year survival: 93.8% (CSA), 73.1% (NSTEACS), 77.5% (STEMI-CS), 28.5% (STEMI+CS).
  • Predictors of excess mortality included renal failure (CSA), preprocedural ventilation (NSTEACS, STEMI-CS), and TIMI 0 flow (STEMI+CS).
  • Multivessel PCI was associated with improved survival.

Conclusions:

  • Long-term survival for UPLMS PCI in chronic stable angina is high and influenced by comorbidities.
  • Preprocedural ventilation is a key determinant of excess mortality in NSTEACS and STEMI-CS.
  • For STEMI+CS, preprocedural TIMI flow is the strongest mortality predictor; non-cardiovascular deaths should be considered in future studies.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.5K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.2K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K